Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07094503 · ClinicalTrials.gov registry record · Phase 2

Adolescent Chatbot

A Phase 2 study of Body Image Disturbance and Disordered Eating Behaviors, sponsored by Washington University School of Medicine.

Recruiting
Registry status
Phase 2
Development phase
400
Enrollment target
1
Study location

NCT07094503: Recruiting Phase 2 study of Body Image Disturbance and Disordered Eating Behaviors, sponsored by Washington University School of Medicine.

NCT07094503 is a Phase 2 study of Body Image Disturbance and Disordered Eating Behaviors that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 400 participants, above the 137-participant average among 5 other Body Image Disturbance trials with a reported enrollment target (192% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07094503, a Phase 2 study of Body Image Disturbance and Disordered Eating Behaviors, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
Phase 2
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test an eating disorders prevention digital chatbot program in a diverse group of adolescents.

Primary Outcome

Weight concerns scale as found in the Stanford Washington Eating Disorder (SWED) screen is a 5-item validated self-report questionnaire which measures concern with weight and dieting. Each item is scored on a 5-100 scale, then an average is computed across all 5 items for a 0-100 score.

Interventions

  • BEHAVIORAL Wysa Digital Chatbot Program

Study Locations (1)

Missouri

  • Washington University in St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-06-18
Est. Completion 2026-05-30
Phase Phase 2

What NCT07094503 shows while recruiting

NCT07094503 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 137-participant average among 5 other Body Image Disturbance trials with a reported enrollment target (192% higher).

The record links to 3 conditions, with Body Image Disturbance appearing as the primary indexed condition, and to 1 intervention - of which Wysa Digital Chatbot Program is the first listed.

NCT07094503 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT07094503 about?

NCT07094503 is a clinical study titled "Adolescent Chatbot". The purpose of this study is to test an eating disorders prevention digital chatbot program in a diverse group of adolescents.

What is the current status of trial NCT07094503?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2024-06-18. Estimated completion is 2026-05-30.

What conditions does trial NCT07094503 study?

This clinical trial studies the following conditions: Body Image Disturbance, Disordered Eating Behaviors, Eating Disorder Prevention.

What interventions are being tested in trial NCT07094503?

The interventions under investigation include: Wysa Digital Chatbot Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07094503?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07094503 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Image Disturbance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07094503, the US trial registry maintained by the National Library of Medicine. NCT07094503 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.